

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. Among its major competitors, MacroGenics is ranked in 11th place for NPS while Genzyme is 1st, and ImmunoGen is 2nd.Their current market cap is $343.82M